Analyst Ratings for Astria Therapeutics (ATXS)

ATXS Rating Summary

  |   Expand Research on ATXS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 2.5 / 10   Percentile Rank: 20%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/12/2025 Cantor Fitzgerald Steven Seedhouse Downgrade Neutral
(Overweight)		 N/A
(N/A)		 12.51
(12.58)		 0.56% Details
10/16/2025 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)		 N/A
(N/A)		 11.92
(12.58)		 5.54% Details